Clinical Trial Update: A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL) [Phase 1]

View source ↗

Summary

Phase 1 study assessing Tolinapant with oral decitabine/cedazuridine and decitabine/cedazuridine alone in relapsed/refractory peripheral T-cell lymphoma; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Decitabine/Cedazuridine (decitabine/cedazuridine)
• Tolinapant (tolinapant)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Relapsed/Refractory Peripheral T-cell Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING